Pharmaceuticals & Therapeutics

As DuPont prepares to reveal a new Tyvek® for ASEAN, the focus shifts from mere compliance to integrating comfort, productivity, and holistic worker safety.

A landmark deal between Cambridge and Australia's UAC gives A-Level students a direct ATAR pathway, signaling a major shift in university admissions.

Preliminary data from a randomized trial suggests a personalized medicine approach can reverse cognitive decline, offering a glimmer of hope beyond slowing the disease.

The AI revolution runs on massive power, but extreme heat threatens stability. A new integrated solution offers a more resilient, safer, and greener grid.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?

A solar cable maker rebrands as PN Smart Energy, pivoting to become a global power provider. It's a bold response to the AI boom's energy demands, but a path fraught with colossal risks.

As AeroVironment preps its year-end report, all eyes are on whether its battlefield-proven technology can meet soaring expectations amid a global arms race.

Bull Moose Tube's deal to acquire Hanna Steel is its third major investment, signaling an aggressive push to dominate the booming North American market.

A Chinese firm is expanding its role in the hidden, high-stakes supply chain for semiconductors and advanced manufacturing. Here’s why it matters.

Facing delisting, J-Star Holding bets its 50-year legacy and a high-stakes battery venture against the unforgiving mechanics of the public market.

L'Oréal Canada's latest buyout via its SalonCentric arm solidifies its Quebec market power, signaling a major strategic shift for stylists and competitors.

In a digital world, the physical print is a statement. A deep dive into the craft, guided by expert Henry McCoy, reveals why materials and process matter.

The FDA's approval of a new Type 1 Diabetes therapy is a landmark. But the real story is the collaborative engine clearing the path for future breakthroughs.

Westlake seizes a German PVC plant from insolvency, a bold move that expands its global footprint and leverages unique logistical advantages on the North Sea.

A new report reveals less than half of Ontario's long-term care homes got proactive inspections, exposing a deep disconnect between policy and resident safety.

Nordicus Partners reveals promising data for gum disease and oral lesions, betting its future on a unique Nordic acquisition strategy and a Nasdaq uplisting.

A strategic integration between Onera Health and ResMed's Somnoware is set to dismantle the biggest barriers in sleep medicine by moving gold-standard tests home.

A new clinical trial, backed by the Michael J. Fox Foundation, tests a radical idea: an oral drug derived from carbon monoxide to fight Parkinson's.

With a new critical illness feature, AuguStar Life is challenging the insurance industry's opaque benefit models with a clear, predictable lien system.

Beyond eco-friendly plastics, Envalior's latest report reveals a strategy built on validated data, making materials a critical node in the sustainability network.